• Journal of Applied Reliability
• /
• v.7 no.3
• /
• pp.127-136
• /
• 2007

The accelerated life tests(ALTs) and degradation characteristics of image intensifier assembly(KIT-7) under low illuminance and high temperature were investigated. The accelerated life tests were carried out at $5{\times}10^5\;fc-40^{\circ}C,\;10{\times}10^5\;fc-40^{\circ}C,\;5{\times}10^5\;fc-50^{\circ}C,\;10{\times}10^5\;fc-50^{\circ}C$ and relationship related to illuminance and temperature was used as an accelerated life test model. An ALTA program[6] was used to calculate an acceleration factor and the test of life distribution fit, and estimate three parameters of an life test model. To sum up, MTTF 10,000 h at $5{\times}10^{-5}\;fc-40^{\circ}C$ of image intensifier assembly was certificated.

• Journal of Sensor Science and Technology
• /
• v.24 no.3
• /
• pp.202-207
• /
• 2015

As a feasibility study on development of a gamma imaging probe, we developed a scintillating film-based gamma imaging detector that can obtain scintillation images with information of gamma-ray distribution. The scintillating film-based gamma imaging detector was composed of a sensing probe, an image intensifier, and a beam profiler. To detect and transmit scintillation image, the sensing probe was fabricated by coupling a scintillating film, a fiber-optic image conduit, and a fiber-optic taper, consecutively. First, the optical images of USAF 1951 resolution target were obtained and then, modulation transfer function values were calculated to test the image quality of the sensing probe. Second, we measured the scintillation images according to the activity of the 137Cs and the distance between the surface of 137Cs and the distal-end of sensing probe. Finally, the intensities of scintillating light as functions of the activity and the distance were evaluated from the region of interest in the scintillation image. From the results of this study, it is expected that a fiber-optic gamma imaging detector can be developed to detect gamma-rays emitted from radiopharmaceuticals during radioimmunoguided surgery.